BankFinancial Corporation Reports Financial Results for the First Quarter 2024
BURR RIDGE, Ill., May 09, 2024 (GLOBE NEWSWIRE) — BankFinancial Corporation (Nasdaq – BFIN) (“BankFinancial”) filed its Quarterly Report on Form […]
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
HIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused […]
23andMe to Report Q4 and Full Year FY2024 Financial Results
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics […]
Innospec Reports First Quarter 2024 Financial Results
Strong contribution from Performance Chemicals drives operating income growth of 23 percent $80.6 million cash generated from operations; Net cash […]
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
NEW HAVEN, Conn., May 09, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) today announced that two posters, including updated […]
Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development
MIDLAND, Pa., May 09, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson,” or “the Company”), a digital […]
Runway Growth Finance Corp. Announces Secondary Offering of Common Stock by Selling Stockholder
MENLO PARK, Calif., May 09, 2024 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (the “Company” or “Runway Growth”) […]
Silver Spike Investment Corp. Reports First Quarter 2024 Financial Results and Announces Cash Dividend of $0.25 Per Share
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) — Silver Spike Investment Corp. (“SSIC” or the “Company”) (NASDAQ: SSIC), a specialty finance […]
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
Presentations highlight data supporting FILSPARI®(sparsentan) as a foundational therapy over historical RASi standard of care and in newly diagnosed patients […]
Mercer International Inc. Reports First Quarter 2024 Results and Announces Quarterly Cash Dividend Of $0.075
Selected Highlights First quarter Operating EBITDA* of $63.6 million and net loss of $16.7 million Improving pulp markets and lower […]
